Sciencast Management’s Evolent Health EVH Stock Holding History

Sciencast Management’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-11,847	Closed	-$132K	–	492
2020 Q3	$132K	Buy	+11,847	New	+$139K	0.05%	362

Other funds holding EVH

Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Sciencast Management's EVH Position: Q4 2020 in Review

Sciencast Management sold out of Evolent Health (EVH) in Q4 2020, closing a stake of 11,847 shares — an estimated $132K sold.

Sciencast Management first reported a position in EVH in Q3 2020 and held it in 1 quarter. The position peaked at $132K in Q3 2020. 161 funds tracked by Wall St. Rank hold EVH as of Q4 2020.

Sciencast Management reported no remaining Evolent Health position as of Q4 2020 after selling out during the quarter.
Sciencast Management sold 11,847 Evolent Health shares in Q4 2020, an estimated $132K.
Sciencast Management first reported a position in Evolent Health in Q3 2020 and held it in 1 quarter.
Sciencast Management's Evolent Health position peaked at $132K in Q3 2020.
161 funds tracked by Wall St. Rank held Evolent Health as of Q4 2020.

Based on Sciencast Management's 13F filing for Q4 2020, filed 4 Feb 2021.